Pono Capital Two, Inc./$SBC
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Pono Capital Two, Inc.
SBC Medical Group Holdings Inc is a management company that provides management services to cosmetic treatment centers mainly in Japan. It is focused on providing comprehensive management services to franchisee clinics, including but not limited to advertising and marketing needs across various platforms (such as social media networks), staff management (such as recruitment and training), booking reservations for franchisee clinic customers, assistance with franchisee employee housing rentals and facility rentals, construction and design of franchisee clinics, medical equipment and medical consumables procurement (resale). The firm generates revenue mostly from these management services.
- Ticker
- $SBC
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 863
- Headquarters
- Irvine, United States
- Website
- sbc-holdings.com
SBC Metrics
BasicAdvanced
$544M
11.07
$0.48
0.63
-
Price and volume
Market cap
$544M
Beta
0.63
52-week high
$5.79
52-week low
$2.78
Average daily volume
192K
Financial strength
Current ratio
3.306
Quick ratio
3.176
Long term debt to equity
0.11
Total debt to equity
0.172
Interest coverage (TTM)
187.88%
Profitability
EBITDA (TTM)
68.634
Gross margin (TTM)
71.85%
Net profit margin (TTM)
27.99%
Operating margin (TTM)
37.34%
Effective tax rate (TTM)
33.79%
Revenue per employee (TTM)
$200,000
Management effectiveness
Return on assets (TTM)
11.33%
Return on equity (TTM)
18.91%
Valuation
Price to earnings (TTM)
11.07
Price to revenue (TTM)
3.098
Price to book
2.06
Price to tangible book (TTM)
2.67
Price to free cash flow (TTM)
8.94
Free cash flow yield (TTM)
11.19%
Free cash flow per share (TTM)
0.592
Growth
Revenue change (TTM)
-6.92%
Earnings per share change (TTM)
45.03%
What the Analysts think about SBC
Analyst ratings (Buy, Hold, Sell) for Pono Capital Two, Inc. stock.
Analyst projections of the future price of Pono Capital Two, Inc. stock.
Bulls say / Bears say
Second-quarter results suggest the 2025 reset may be giving way to renewed growth: revenue rose 13% year on year, adjusted EBITDA rose 32% and attributable net income increased to $11 million from $2 million. (SBC Medical Group Holdings, Inc.)
Revised management and call-centre fees are expected to add about $15 million to annual service revenue once fully reflected, giving the earnings recovery a potential recurring revenue tailwind. (SBC Medical Group Holdings, Inc.)
The supported clinic network added 34 sites to 287, while annual visits rose 10% and average spend per visit climbed 9%, showing growth in both customer volume and spend. (SBC Medical Group Holdings, Inc.)
Despite the Q2 rebound, first-half revenue grew only 2%, while attributable net income fell 8% and adjusted EBITDA fell 4%; the recovery has not yet restored year-to-date growth. (SBC Medical Group Holdings, Inc.)
The company’s chief executive has described a crowded Japanese aesthetics market, where clinic supply expanded faster than demand and competition intensified. That pressure could weigh on growth and margins. (Diamond Online)
After a director’s departure, SBC fell below Nasdaq’s board-independence and audit-committee requirements. It must restore compliance by the applicable cure deadline, creating governance and listing risk if it fails. (StockTitan)
Data summarised monthly by Lightyear AI. Last updated on 30 Oct 2026.
SBC Financial Performance
Revenues and expenses
SBC Earnings Performance
Company profitability
Upcoming events
No upcoming events
SBC News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.